Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Dong‐Ju Choi et al.|New England Journal of Medicine|2021Cited by 4.6k
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection FractionMilton Packer, Faı̈ez Zannad, Stefan D. Anker et al.|Circulation|2020Cited by 422
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faı̈ez Zannad et al.|Circulation|2021Cited by 343
Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic DysfunctionMark C. Petrie, Eric J. Velazquez, Pardeep S. Jhund et al.|Circulation|2016Cited by 168